An all-in-one nanoparticle (AION) contrast agent for breast cancer screening with DEM-CT-MRI-NIRF imaging.

Hsu, Jessica C; Naha, Pratap C; Lau, Kristen C; Chhour, Peter; Hastings, Renee; Moon, Brianna F; Stein, Joel M; Witschey, Walter R T; McDonald, Elizabeth S; Maidment, Andrew D A; Cormode, David P

Hsu, Jessica C; Naha, Pratap C; Lau, Kristen C; Chhour, Peter; Hastings, Renee; Moon, Brianna F; Stein, Joel M; Witschey, Walter R T; McDonald, Elizabeth S; Maidment, Andrew D A; Cormode, David P.

Affiliation

Hsu JC; Department of Radiology, University of Pennsylvania, 3400 Spruce St, 1 Silverstein, Philadelphia, PA 19104, USA. david.cormode@uphs.upenn.edu.

Nanoscale ; 10(36): 17236-17248, 2018 Sep 20.

Article in En | MEDLINE | ID: mdl-30191237

Subject(s)

Breast Neoplasms/diagnostic imaging; Contrast Media/chemistry; Nanoparticles/chemistry; Animals; Cell Line; Early Detection of Cancer; Female; Ferric Compounds; Hep G2 Cells; Humans; Magnetic Resonance Imaging; Mammography; Mice, Nude; Neoplasms, Experimental/diagnostic imaging; Phantoms, Imaging; Silver Compounds; Tomography, X-Ray Computed

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Contrast Media / Nanoparticles Type of study: Diagnostic_studies / Screening_studies Limits: Animals / Female / Humans Language: En Journal: Nanoscale Year: 2018 Document type: Article

Fulltext

XML

PubMed Links

Search on Google